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Abstract
GPCR desensitization and down-regulation are considered key molecular events underlying the development of tolerance
in vivo. Among the many regulatory proteins that are involved in these complex processes, GASP-1 have been shown to
participate to the sorting of several receptors toward the degradation pathway. This protein belongs to the recently
identified GPCR-associated sorting proteins (GASPs) family that comprises ten members for which structural and functional
details are poorly documented. We present here a detailed structure–function relationship analysis of the molecular
interaction between GASPs and a panel of GPCRs. In a first step, GST-pull down experiments revealed that all the tested
GASPs display significant interactions with a wide range of GPCRs. Importantly, the different GASP members exhibiting the
strongest interaction properties were also characterized by the presence of a small, highly conserved and repeated ‘‘GASP
motif’’ of 15 amino acids. We further showed using GST-pull down, surface plasmon resonance and co-immunoprecipitation
experiments that the central domain of GASP-1, which contains 22 GASP motifs, is essential for the interaction with GPCRs.
We then used site directed mutagenesis and competition experiments with synthetic peptides to demonstrate that the
GASP motif, and particularly its highly conserved core sequence SWFW, is critically involved in the interaction with GPCRs.
Overall, our data show that several members of the GASP family interact with GPCRs and highlight the presence within
GASPs of a novel protein-protein interaction motif that might represent a new target to investigate the involvement of
GASPs in the modulation of the activity of GPCRs.
Citation: Bornert O, Møller TC, Boeuf J, Candusso M-P, Wagner R, et al. (2013) Identification of a Novel Protein-Protein Interaction Motif Mediating Interaction of
GPCR-Associated Sorting Proteins with G Protein-Coupled Receptors. PLoS ONE 8(2): e56336. doi:10.1371/journal.pone.0056336
Editor: Claudio M. Costa-Neto, University of Sa˜o Paulo, Brazil
Received October 2, 2012; Accepted January 8, 2013; Published February 18, 2013
Copyright:  2013 Bornert et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Ministe`re de l’Education Nationale de l’Enseignement Supe´rieur et de la Recherche (MENSER) fellowship, Association pour
la Recherche sur le Cancer (Nu3423), Fondation pour la Recherche Me´dicale, Centre National de la Recherche Scientifique, Universite´ Louis Pasteur, the Lundbeck
Foundation Center for Biomembranes and Nanomedicine, and the programs BioScaRT and UNIK Synthetic Biology. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: O. Bornert is an employee of the company BioXtal. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data
and materials.
* E-mail: simonin@unistra.fr
Introduction
G protein-coupled receptors (GPCRs) represent one of the most
diversified protein families in humans. They modulate a large
panel of physiological processes making them unrivalled targets for
development of new therapeutic agents. GPCRs translate extra-
cellular stimuli into intracellular signals, and the intensity and
duration of these are determined by complex regulation mecha-
nisms. Internalization, whereby agonist-activated GPCRs are
rapidly silenced by translocation from the cell surface to endocytic
compartments, represents a central event for the modulation of
receptor activity [1]. Upon internalization, GPCRs can be
recycled back to the membrane or degraded. Although mecha-
nisms that govern the postendocytic fate of GPCRs are not fully
understood, several proteins have been shown to modulate this
phenomenon via a direct interaction with their carboxyl-terminal
intracellular tail (C-tail) [2–5]. One of these regulatory proteins is
GPCR-associated sorting protein 1 (GASP-1), which was identified
in a yeast two-hybrid screen using the d-opioid receptor (DOR)
cytoplasmic C-tail as bait [6,7] and has been shown to be involved
in the sorting of receptors that are quickly degraded following
agonist-promoted internalization [7]. This phenomenon has been
proposed to form the molecular basis for analgesic tolerance to
cannabinoids [8,9]. GASP-1 was also found to interact with
numerous other receptors both in vitro [6,7,10] and in vivo [11,12].
Although, its has been proposed that the binding epitope for
GASP-1 to these receptors is large an covers major parts of the
cytoplasmic C-tail of receptors (Heydorn et al., 2004), we have
shown that helix 8, located near the seventh transmembrane helix,
is critically involved in this interaction [6]. Concerning GASP-1,
little is known about which region within this protein is required
for its interaction with GPCRs.
GASP-1 is part of a novel protein family of ten members that
were identified by sequence homology searches [6,13]. The
carboxyl-terminal 250 amino acids (AA) region of GASP-1
displays remarkable sequence identity with the nine other
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members of the family. Furthermore, GASP genes, except GASP-
8, contain a single coding-exon and are located within two 200-
kilobase clusters on two adjacent contigs on chromosome X,
suggesting that they arose from a common ancestral gene [13,14].
Altogether, these data indicate that GASPs do indeed form a
protein family and might display similar functions. However,
except GASP-1 and GASP-2, interaction of the other members of
the family with GPCRs has not been investigated so far.
In this study, we present a detailed structure–function relation-
ship analysis of the molecular interaction between GASPs and
GPCRs. GST-pull down experiments revealed that, besides
GASP-1 and GASP-2, different members of the GASP family
can interact with a wide range of GPCRs. Using surface plasmon
resonance (SPR) analysis with two full-length GPCRs in solution
and co-immunoprecipitation of GPCRs expressed in HEK293
cells, we further showed that the central domain of GASP-1 is
critical for its interaction with GPCRs. Finally, we identified
within this domain and in several other GASPs a conserved and
repeated sequence of 15 amino acids that we called ‘‘GASP motif’’
and demonstrated that this motif plays a critical role in the
interaction with GPCRs, both by site directed mutagenesis and
competition experiments with synthetic peptides. Overall, our
results demonstrate that GASPs indeed represent a novel family of
GPCR-interacting proteins that can be divided into two subfam-
ilies depending on the presence of the GASP motif. Our data
clearly show that this sequence represents a novel protein–protein
interaction motif that is critical for the interaction between GASPs
and GPCRs.
Materials and Methods
Materials
The pGEX-2T and pGEX-4T3 prokaryotic expression vectors
were purchased from Amersham Biosciences (GE Healthcare) and
the pcDNA3.1 eukaryotic expression vector was from Invitrogen.
The cDNA encoding GASP-3 was obtained from the Kazusa
DNA Research Institute (Chiba, Japan; http://www.kazusa.or.jp/
huge/) and cDNAs encoding GASP-6, -7, and -9 cloned into
pBluescript II SK (+) were from Invitrogen. Radiolabelled [35S]-
Methionine was purchased from ICN. GASP peptide
(RVKQEPRFEEEVIIGSWFWAEKEA), control peptide
(RVKQEPRFEEEVIIGAAAAAEKEA) and scramble peptide
(AVEWIQEVFWEKRKPEEFGIERAS) were from Genecust
with a $85% purity grade.
Production of GST-fused Proteins
cDNAs encoding the cytoplasmic C-tail of 14 GPCRs and 2
one-transmembrane receptors were cloned into the pGEX-2T
prokaryotic expression vector downstream the GST sequence. The
following pGEX constructs were engineered: pGEX-DOR
encoding residues 314–372 of the d-opioid receptor (referring to
Swiss-Prot accession number U10504), pGEX-MOR encoding
residues 334–400 of the m-opioid receptor (L29301), pGEX-KOR
encoding residues 326–380 of the k–opioid receptor (U17298),
pGEX-ORL1 encoding residues 315–370 of the opioid receptor-
like 1 (X77130), pGEX-M1 encoding residues 414–460 of the
muscarinic M1 acetylcholine receptor (X52068), pGEX-M2
encoding residues 436–466 of the muscarinic M2 acetylcholine
receptor (M16404), pGEX- ADRB1 encoding residues 373–477 of
the b1 adrenergic receptor (J03019), pGEX-ADRB2 encoding
residues 322–413 of the b2 adrenergic receptor (P07550), pGEX-
CALCR encoding residues 407–490 of the calcitonin receptor
(L00587), pGEX-CNR2 encoding residues 295–360 of the
cannabinoid type 2 receptor (P34972), pGEX-5HT7 encoding
residues 380–445 of the 5-hydroxytryptamine 7 receptor (L21195),
pGEX-H2 encoding residues 284–349 of the histamine 2 receptor
(S57565), pGEX-TXA2 encoding residues 304–343 of the a
isoform of the thromboxane A2 receptor (D38081), pGEX-FZ4
encoding residues 493–537 of the frizzled 4 receptor (AB032417),
pGEX-TGFb encoding residues 805–849 of the type III
transforming growth factor b receptor (L07594), pGEX-IGF1
encoding residues 1268–1367 of the insulin growth factor I
receptor (X04434). Free GST was produced by using the pGEX-
4T3 expression vector without insert. The same plasmid was used
to clone the cDNA encoding a central domain of GASP-1,
corresponding to amino acids 380 to 1073, downstream the GST
sequence. All these plasmids were transformed into the Escherichia
coli BL21 strain and expression was induced using 1 mM of
isopropylthiogalactoside for 2 h at 37uC. Bacteria were then
pelleted, resuspended in PBS supplemented with cOmplete
protease inhibitors (Roche), lysed at 1.5 kbar using a basic Z cell
disrupter (constant system) and finally the lysates were cleared by
centrifugation (10,000g, 15 min, 4uC).
[35S]-labelled GASPs in vitro Production
cDNAs encoding GASP-1 and GASP-2 were cloned into the
pcDNA3 eukaryotic expression vectors [6]. cDNAs encoding
GASP-3, -6, -7, and -9 were subcloned into pcDNA3.1 vectors. All
the clones were controlled by DNA sequencing. The in vitro
production was performed by using the TNT Quick-coupled
Transcription/Translation T7 kit (Promega) in presence of [35S]-
Methionine according to the instructions from the manufacturer.
GST-pull Down Assay
GST-fusion proteins were immobilized on glutathione-coupled
Sepharose beads (GE Healthcare) for 1 h at 4uC and incubated
with [35S]-labelled in vitro translated GASP proteins or their
truncated or mutated forms in ice-cold binding buffer containing:
20 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM
DTT, 10% glycerol and 1% Triton X-100. The mixture was
incubated for 1 h at 4uC with gentle rocking. The beads were
washed five times with the same ice-cold buffer, resuspended in
30 ml SDS-PAGE sample buffer, incubated 10 min at 65uC, and
pelleted for 60 s at 3000 g. The supernatants were then analyzed
by SDS-PAGE, the gels were stained with Coomassie blue to
visualize GST-fusion proteins, dried and analyzed using a
Phosphor-imager (Personal Molecular Imager FX, Biorad) to
visualize [35S]-labelled GASPs. Quantification was performed with
the Quantity One software (Biorad). GST-pull down quantifica-
tion data were analyzed using GraphPad Prism 4.03 (GraphPad
Software). Quantifications presented are means of at least three
independent experiments.
GST-pull Down Competition Experiments
GASP peptide or its corresponding scrambled version was
incubated with GST-fused proteins and [35S]-labelled GASPs and
the binding was analyzed as described for the GST-pull down
assay. In a first step, dose-effects of GASP peptides were assessed
in competition experiments between [35S]-labelled GASP-2 and
GASP peptides (concentrations ranging from 1 to 250 mM) for the
interaction with GST-ADRB1. Subsequent competition experi-
ments with other GASPs and GPCR C-tails were performed by
using a single GASP peptide concentration of 150 mM.
Production and Purification of Full-length GPCRs
The human ADRB2 and CNR2 receptors were produced using
the P. pastoris expression system as previously described [15,16].
The GASP Motif Mediates GASP-GPCR Interaction
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After methanol-induced receptor expression, cells were washed
with PBS pH 7.0 and resuspended in ice-cold buffer A (50 mM
Tris-HCl pH 7.4, 500 mM NaCl, 10% glycerol, 5 mM EDTA,
1 mM PMSF, 2 mM DDT). Cells were then lysed with two cycles
of 20 s shaking and 20 s cooling on ice using 0.5 mm glass beads
in a FastPrep 24 device. Unbroken cells and cell debris were
removed by centrifugation (3000 g, 5 min, 4uC) and the mem-
brane fraction from the supernatant was pelleted by ultracentri-
fugation (100,000 g, 45 min, 4uC). Membranes were resuspended
in buffer B (50 mM Tris-HCl pH 7.4, 500 mM NaCl, 10%
glycerol, 1 mM PMSF, 2 mM DTT) using a Dounce homoge-
nizer, and then successively washed with urea (buffer B with 4 M
urea) and NaOH (buffer B with 10 mM NaOH), and ultracen-
trifuged (100,000 g, 45 min, 4uC). Finally membranes were
resuspended in buffer B and quantified with the bicinchoninic
acid (BCA) method (Pierce).
Approximately 150 mg membrane proteins were extracted by
5 min incubation at room temperature in buffer C (50 mM Tris-
HCl pH 7.4, 500 mM NaCl, 10% glycerol, 1 mM PMSF, 2 mM
DTT, 50 mM imidazole, 1% (w/v) DDM, 0.1% (w/v) CHS). The
solubilized proteins were separated from the remaining membrane
fraction by ultracentrifugation (100,000g, 45 min, 4uC) and loaded
on a HisTrap 1 ml HP column (GE Healthcare). The column was
washed successively with buffer D (50 mM Tris-HCl pH 7.4,
500 mM NaCl, 10% glycerol, 1 mM PMSF, 2 mM DTT, 50 mM
imidazole, 0.1% (w/v) DDM, 0.01% (w/v) CHS), buffer D with
2 M NaCl, buffer D with 1 M sodium thyocianate, buffer D with
1% CHAPS, and finally buffer D alone. The proteins were eluted
with buffer E (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 300 mM
imidazole, 0.1% DDM, 0.01% CHS). Imidazole was removed
from the eluted fraction using a HiTrap 5 ml desalting column
(GE Healthcare), purified proteins were quantified using the BCA
assay (Pierce) and receptor integrity was analyzed by SDS-PAGE.
Purification of Free GST and GST-fused Central Part of
GASP-1
Free GST or GST-fused central part of GASP-1 (AA 380–1073)
were purified on an A¨KTApurifier (GE Healthcare) using a
GSTrap 4B 1 ml column (GE Healthcare) according to the
instructions from the manufacturer. Proteins were eluted with a
buffer containing 50 mM Tris-HCl pH 8.0 and 10 mM reduced
glutathione. The buffer was finally exchanged for 50 mM Tris-
HCl pH 8.0 and glycerol 10% using a HiTrap 5 ml desalting
column (GE Healthcare). Purified proteins were quantified using
the BCA assay (Pierce), analyzed by SDS-PAGE and stored at
280uC.
SPR Measurements
A Biacore X100 SPR instrument (GE Healthcare) equilibrated
to 25uC and equipped with a Sensor Chip CM5 (GE Healthcare)
was used for all SPR measurements.
Affinity purified polyclonal anti-GST antibody (GE Healthcare)
was covalently immobilized in two flow cells using Amine
Coupling Kit (GE Healthcare) with a running buffer containing
10 mM HEPES pH 7.4, 150 mM NaCl, 0.05% Surfactant P-20
(GE Healthcare) and 3 mM EDTA and a flow rate of 5 ml/min.
50 mg/ml antibody in 10 mM sodium acetate pH 5.0 was injected
for 5 min to a surface activated by a 7 min injection of a 1:1
mixture of 0.4 M 1-ethyl-3-(3-dimetrylaminopropyl) carbodiimide
HCl and 0.1 M N-hydroxysuccinimide. The remaining active
groups were deactivated by a 7 min injection of 1 M ethanolamine
HCl pH 8.5. This procedure resulted in immobilization of more
than 10000 resonance units (RU < pg/mm2 [17]) of anti-GST
antibody.
Capture and binding experiments were performed with a
running buffer containing 50 mM Tris-HCl pH 7.4, 150 mM
NaCl, 0.1% DDM, and 0.01% CHS. Each binding cycle started
with capture of GST in the first flow cell by a 0.5–1 min injection
of 12.5 nM GST, followed by a 0.5–1 min injection of 94 nM of
GST-tagged central domain of GASP-1 in the second flow cell and
ended with regeneration by a 2 min injection of 10 mM glycine-
HCl pH 2, all at a flow rate of 10 ml/min. Typical capture
densities were 50–150 Resonance Units (RU) for GST and 100–
200 RU for the central domain of GASP-1. No significant
dissociation of the captured proteins was observed in the
experimental time frame.
For saturation binding, a range of ADRB2 or CNR2
concentrations were injected after GST and GASP capture. For
peptide competition, a fixed concentration of ADRB2 and CNR2
was mixed with a range of GASP peptide or control peptide
concentrations and incubated for at least 1 h before injection.
Several blank cycles were included for all samples. For the
competition curves, an additional blank injection with the
appropriate concentration of peptide was injected just before the
injection of the peptide and receptor mixture. For all sample
injections, the contact time was 3 min, the dissociation phase was
3 min, and the flow rate was 30 ml/min.
The binding curves were double referenced by (i) subtraction of
the signal from the GST captured flow cell from the signal of the
flow cell with captured central domain of GASP-1 and (ii)
subtraction of the appropriate blank injection from the receptor
injections with or without peptide [18]. The curves were adjusted
for the slightly decreasing GASP capture density during a binding
series (20–40 RU from the first to the last GASP capture) by
normalization to the response from the first GASP capture. The
high peptide concentrations resulted in large spikes at the
beginning and end of each injection; these points were clearly
artifacts and they were removed for presentation purposes.
Endpoint responses were read 20 s after injection end.
The double-referenced dose-response curves were fitted with
Biacore X100 Evaluation Software 2.0.1 (GE Healthcare). The
dissociation phases were first fitted separately to a one-to-one
binding model to obtain the dissociation rate constants. The
association and dissociation phases were then fitted simultaneously
to a model with two parallel independent one-to-one reactions
(heterogeneous ligand), with the dissociation rate constants fixed to
the single value found by fitting of the dissociation phases
separately. The mass transport contribution was negligible in
both data sets. The two association rate constants obtained from
these fits were used to estimate the affinity ranges. All curves were
fitted by global analysis [18].
Co-immunoprecipitation Experiments
HEK293 cells stably expressing N-terminal GFP-tagged
ADRB1, ADRB2, CALCR and M1 or MyrPalm-mYFP were
transfected with pcDNA3.1 containing the sequence for a central
domain of GASP-1 (AA 380 to 1073) using JetPEI reagent
(polyplus transfection) according to the instructions from the
manufacturer. After 48 h of expression, cells were washed twice
with PBS and lysed in a buffer containing 10 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 25 mM KCl, 0.3% Triton X-100 and
cOmplete protease inhibitors (Roche) for 1 h at 4uC under
agitation. 500 mg of cleared lysates were incubated with 1 mg of a
mouse monoclonal anti-GFP antibody (Invitrogen) overnight at
4uC, followed by an incubation with 40 ml of protein A-Sepharose
beads for an additional 2 h at 4uC. Beads were then washed five
times in lysis buffer and precipitates were resolved on an 8% gel by
SDS–PAGE and electrotransferred to immobilon-P membranes
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(Millipore) in 50 mM Tris-boric acid for 1 h at 300 mA.
Membranes were blocked with 5% non-fat powder milk in TBS-
Tween (50 mM Tris-HCl pH 8, 150 mM NaCl, 0.4% Tween-20)
for 1 h at room temperature. Detection of GFP-tagged receptors
was performed by a 2 h incubation of the blots with goat anti-GFP
coupled to horseradish peroxidase-conjugated antibody (Abcam;
1:10,000). For GASP detection, blots were incubated for 1 h with
anti-GASP polyclonal serum from rabbit (1:2,500) and for 1 h
with HRP-conjugated anti-rabbit antibody (New England Biolabs;
1:5,000). For immunodetection of GASP or GFP-tagged receptors
directly from cell lysates, 10 mg of proteins were loaded on SDS
gels and analyzed following the procedure described above.
Finally, membranes were washed in TBS-Tween and detected by
chemiluminescence (ECL prime, GE Healthcare).
Results
GASPs form a Family of G Protein-coupled Receptor
Interacting Proteins
In our previous study we have shown that GASP-1 and GASP-2
interact with the carboxyl-terminal domain of several GPCRs.
Based on sequence homology searches, we identified eight
additional members of the GASP family ([6,13]; Figure 1). All
members display sequence similarities in their carboxyl-terminal
domain (last 250 amino acids) and the first five members contain a
repeated motif of 15 amino acids outside this domain, that we
named the GASP motif (Figure 1). Moreover, a crosswise
comparison of the conserved carboxyl-terminal domain of the
different members of the GASP family revealed very high
sequence similarities between GASP-1 and GASP-2 as well as
high similarities between GASP-6, -7, -8 and -9 (Figure S1).
Although GASP-1 and GASP-2 have been shown to interact with
GPCRs [6,7,10], there is no experimental evidence showing that
the other members of the GASP family also interact with these
receptors. In order to examine this possibility we performed GST-
pull down experiments with radiolabelled GASP-1, -2, -3, -6, -7,
and -9 and the cytoplasmic C-tail of twelve GPCRs fused to GST
(Figure S2), all comprising the helix 8 that was shown to be
critically involved in the interaction with GASP-1. As controls, we
used free GST and GST-fused C-tails of the type III transforming
growth factor b receptor (TGFb) and the insulin growth factor I
receptor (IGF1), which are non-GPCR receptors. Equivalent
amounts of radiolabelled GASPs were incubated with saturating
concentrations of GST-fused receptor C-tails immobilized on
glutathione-sepharose beads. Radiolabelled proteins that were
retained by receptor C-tails were then analyzed by SDS-PAGE
and quantified by Phosphor-imaging. As shown in Figure 2, the
two non-GPCR receptor C-tails (TGFb and IGF1) did not interact
with any GASPs (Figure 2A–B). Although sometimes weak, we
observed significant interactions of the tested GASPs with several
GPCR C-tails.
Based on their interactions with the C-tail of GPCRs, we
identified two GASP subfamilies. The first subfamily, including
GASP-1, -2, and -3, displayed strong interaction (.10% of GASP
input) with most GPCR C-tails tested (Figure 2A). The best GPCR
interacting partners were the b1 adrenergic receptor (ADRB1), the
calcitonin receptor (CALCR), and the a isoform of the throm-
boxane A2 receptor (TXA2), which all retained from 30% to 50%
of GASP inputs. Furthermore, the atypical frizzled 4 receptor
(FZ4) also displayed strong interaction with GASP-1 and GASP-3.
The other GPCRs displayed medium to low interaction levels
(,10% of GASP input). Among the opioid receptors, only DOR
showed significant interactions with GASP-1, as shown earlier
[6,7]. The second subfamily, including GASP-6, -7, and -9,
showed weak (GASP-7) to very weak (GASP-6 and -9) interactions
with GPCR C-tails (Figure 2B). The best interacting partners for
GASP-7 were muscarinic M1 acetylcholine receptor (M1),
ADRB1, CALCR, TXA2 and FZ4 that retained from 6% to
10% of the GASP-7 input. Some receptor C-tails, including DOR,
M1, ADRB1, CALCR, histamine H2 receptor and TXA2, retained
around 2% of GASP-6 or GASP-9 inputs, while controls retained
less than 1% of both inputs.
Altogether, these results show that in addition to GASP-1 and -
2, other members of the GASP family can interact with a wide
range of GPCR C-tails. As describe in Figure 1, members of the
GASP subfamily 1 contain 22 (GASP-1) or 2 repeated (GASP-2 to
-5) GASP motif. Combined with the fact that subfamily 1 displays
a higher level of interaction with GPCR C-tails compared to
subfamily 2, this observation prompted us to investigate the
significance of the GASP motif in the interaction with GPCRs.
Two Regions of GASP-1 are Involved in the Interaction
with the C-tail of GPCRs
In a previous study, we have shown that the carboxyl-terminal
region of GASP-1, corresponding to AA 924 to 1395, displays a
strong interaction with the DOR C-tail [6]. Within this region, a
250 AA carboxyl-terminal domain displays high sequence
similarities with the other GASPs (Figure 1). We therefore
hypothesized that this conserved carboxyl-terminal domain could
be critical for the interaction of GASPs with GPCRs. To test this
hypothesis, we assessed the interaction of three GPCR C-tails,
DOR, ADRB1 and M1, that display medium to strong interaction
with GASPs (Figure 2A), with truncated mutants of GASP-1 in
GST-pull down experiments.
In a first set of experiments, we tested three truncated mutants
of GASP-1: mutant 380–1395 that lacks the N-terminal part,
mutant 1025–1395 corresponding to the conserved C-terminal
domain, and mutant 380–1073 corresponding to a central portion
of GASP-1 that contains 19 GASP motif. As shown in Figure 3A,
DOR, ADRB1 and M1 C-tails interacted similarly with full-length
GASP-1 and mutant 380–1395, indicating that the N-terminal
Figure 1. Schematic comparison of GASP family members. Black
boxes represent the conserved carboxyl-terminal domain of 250 amino
acids. The percentage of identical amino acids shared with GASP-1 is
indicated within each box. Small grey boxes represent a highly
conserved motif of 15 amino acids that is repeated 22 times in GASP-
1 and two times in GASP-2 to -5. The consensus sequence of this motif
is: (E/D/G) (E/D) E X (I/L/V/S/T) (I/V/A/F) (G/N) (S/T) W F W (A/V/T/S/D/E)
(G/E/R) (E/D/K) (E/D/K/A/Q). For GASP-2, two regions showing
significant sequence homology with GASP-1 are separated by a gap
represented by dotted lines. GASPs accession numbers from SPtrEMBL
database are indicated on the left of the figure.
doi:10.1371/journal.pone.0056336.g001
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portion of GASP-1 is not implicated in the interaction with
GPCRs. Unexpectedly, the conserved C-terminal domain did not
display detectable interactions with the ADRB1 or M1 C-tails and
interacted only weakly with DOR. Conversely, the central domain
of GASP-1 retained around 70% of interaction with ADRB1 and
M1 C-tails and 30% with DOR. These data suggest that the
central domain of GASP-1 is necessary and sufficient for the
interaction with ADRB1 and M1 receptors, while both the central
and C-terminal domains of GASP-1 are important for the
interaction with DOR.
In order to delineate more precisely which regions of GASP-1
are important for the interaction with DOR, we evaluated the
interaction of the DOR C-tail with four additional truncated
mutants of GASP-1 (Figure 3B). The first two were derived from
mutant 1025–1395 by extension with 50 or 100 AA at the N-
terminus to include one or two GASP motifs (mutants A and B)
and the other two were derived from mutant 924–1395, which
contains 2 GASP motifs, by deletion of 45 or 95 AA from the C-
terminus (mutants C and D). When incubated with DOR C-tail,
mutants A and B displayed increasing interaction compared to the
C-terminal domain of GASP-1, which were similar to those
obtained with full-length GASP-1. Mutant C displayed strong
interaction as well, while it was completely lost with mutant D.
Altogether, these results indicate that the GASP motifs from the
central domain are important to warrant full interaction with
DOR and that the integrity of the GASP-1 carboxyl-terminal
portion is required for this interaction. From these results we
identified two types of interactions between GPCRs and GASP-1:
some GPCRs interact exclusively with the central part of GASP-1
Figure 2. GST-pull down experiments with radiolabelled GASP-1, -2, -3, -6, -7 and -9 and GST-fused receptor C-tails. A, GASP-1, -2 and
-3 showed medium to strong interactions with some GPCR C-tails but no interaction was detected with the two one-transmembrane receptor C-tails
(TGFb and IGF1). B, GASP-7 showed weak to medium interactions with some GPCR C-tails. GASP-6 and -9 showed very weak interactions with all
tested receptors. No interaction was detected with TGFb and IGF C-tails. Data were quantified by Phosphor-imaging. Results are shown as percent of
the [35S]-GASPs input retained by the GST-fused receptor C-tails and correspond to the mean 6 S.E.M of three independent experiments. Lower
panels correspond to representative gel images. 5HT7, 5-hydroxytryptamine 7 receptor; ADRB1, b1 adrenergic receptor; CALCR, calcitonin receptor;
DOR, d-opioid receptor; FZ4, frizzled 4 receptor; H2, histamine 2 receptor; IGF1, insulin growth factor I receptor; KOR, k-opioid receptor; M1, muscarinic
M1 acetylcholine receptor; M2, muscarinic M2 acetylcholine receptor; MOR, m-opioid receptor; ORL1, opioid receptor-like 1; TXA2, a isoform of the
thromboxane A2 receptor; TGFb, type III transforming growth factor b receptor.
doi:10.1371/journal.pone.0056336.g002
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(e.g. ADRB1 and M1), while others interact with the central and
the carboxyl-terminal portions of GASP-1, like DOR.
Purified Full-length Receptors Bind dose-dependently to
the Central Domain of GASP-1
In order to further characterize the importance of the central
part of GASP-1 for the interaction with GPCRs, we evaluated the
interactions between a central domain of GASP-1 (AA 380 to
1073), which contains 19 GASP motifs, and two purified full-
length GPCRs: the b2 adrenergic receptor (ADRB2) and the
cannabinoid receptor type 2 (CNR2). We first showed that the C-
Figure 3. Two portions of GASP-1 are implicated in the
interaction with GPCRs. A, GST-pull down experiments with three
truncated mutants of GASP-1 and DOR, ADRB1 and M1 C-tails. Deletion
analysis revealed the critical role played by the central part of GASP-1
(380–1073) in the interaction with the DOR, ADRB1 and M1 C-tails and
especially with ADRB1 and M1. Surprisingly, the conserved carboxyl-
terminal part of GASP-1 (1025–1395) displayed no significant interaction
with these receptor C-tails, except DOR for which a 25% interaction was
observed. B, GST-pull down experiments with additional truncated
mutants of GASP-1 and DOR C-tail. Detailed deletion analysis showed
that the interaction with DOR C-tail required the entire carboxyl-
terminal part as well as the central part of GASP-1. Results are
represented as percent of the full-length GASP-1 interaction and
correspond to the mean 6 S.E.M of three independent experiments.
doi:10.1371/journal.pone.0056336.g003 Figure 4. Purified full-length GPCRs dose-dependently bind to
the central domain of GASP-1 in SPR experiments. A, Interaction
of the central domain of GASP-1 compared to the full-length protein
with GST-fused ADRB2 and CNR2 C-tails by GST pull down experiments.
The results show that both receptors interact in vitro with GASP-1 and
that the central part of GASP-1 is strongly involved in the interaction
with ADRB2 and CNR2. B, Binding of a range of concentrations of
ADRB2 to the central domain of GASP-1. C, Binding of a range of
concentrations of CNR2 to the central domain of GASP-1. Overall, we
observed a dose-dependent binding of ADRB2 and CNR2 with the
central domain of GASP-1. The receptor concentrations are indicated on
the figures. All curves are double referenced and corrected for changes
in capture density of the central domain of GASP-1. ADRB2, b2
adrenergic receptor; CNR2, cannabinoid receptor type 2.
doi:10.1371/journal.pone.0056336.g004
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tails of these two receptors interact with GASP-1 in GST Pull-
down experiments and that the central domain of GASP-1 is
mandatory and sufficient for this interaction (Figure 4A), which is
in agreement with previous observation for ADRB1 and M1
(Figure 3A).
Both ADRB2 and CNR2 full-length receptors were produced in
P. pastoris and purified as previously described [15,16], while GST-
tagged central domain of GASP-1 was purified from BL21 E. coli
strain (Figure S3). Biacore SPR was used to monitor the binding of
GPCRs to GASP-1 in real-time and thus to determine the kinetics
and the affinity of the GASP-1–GPCR interactions. The GST-
tagged central domain of GASP-1 was first captured with anti-
GST antibodies immobilized on a CM5 sensor chip. As a control,
free GST was captured in another flow cell of the sensor chip. A
range of concentrations of the purified GPCRs was then injected
in both flow cells and the interaction was monitored as a function
of time. All curves were double referenced by subtraction of the
signal from the GST and from the buffer of receptor injections.
Using this set-up we observed dose-dependent binding of ADRB2
and CNR2 to the central domain of GASP-1 (Figure 4B–C). The
kinetics of the two interactions were very similar: both interactions
were very stable and had a slow association rate. For both sets of
binding curves, we found complex kinetics in the association phase
and a unimodal dissociation phase (Figure S4). Analysis of the
dissociation phases showed a dissociation rate constant of
kd = 4.560.1610
24 s21 for ADRB2 and kd = 6.560.1610
24 s21
for CNR2. The complex association phases did not allow accurate
determination of the association rate constants, but we estimated
the dissociation constant Kd to be in the ranges , 14–140 nM for
ADRB2 and , 5–50 nM for CNR2.
The Central Domain of GASP-1 Interacts with GPCRs in
Cells
To confirm the relevance of our previous observations we
sought to examine the interaction between different GPCRs and
the central domain of GASP-1 in a cellular context. To this
purpose we performed co-immunoprecipitation experiments from
HEK cells stably expressing GFP-tagged ADRB1, ADRB2,
CALCR or M1 receptor, transfected with the central domain of
GASP-1 (AA 380-1073). As expected, the four GFP-tagged
GPCRs where mainly localized at the plasma membrane while
the central domain of GASP-1 displayed a cytoplasmic distribution
that was similar to that observed for the full length GASP-1 [7]. As
shown in Figure 5, the central domain of GASP-1 co-immuno-
precipitated with the four different GPCRs but not with
myristoylated-palmitoylated mYFP (MyrPalm-mYFP), which is
targeted to the plasma membrane and particularly enriched in
lipid rafts where GPCRs are also preferentially targeted [19].
These data demonstrated that the central part of GASP-1 displays
binding activity for full length GPCRs in a cellular context, thus
confirming the relevance of our in vitro measurements with
carboxyl-terminal tails or purified receptors.
The GASP Motif is Critical for the Interaction of GASPs
with GPCRs
Results obtained with GASP-1 truncated mutants, SPR and co-
immunoprecipation experiments pointed to the GASP motifs from
the central domain of GASP-1 as critical elements for interaction
with GPCRs. This conserved motif is also present twice in the
corresponding central parts of GASP-2 to GASP-5, thus suggest-
ing that it could also play an important role in the interaction
between GPCRs and these GASP subfamily members. Thus, we
evaluated the interaction of truncated GASP-2 mutants with GST-
fused ADRB1, M1, and CALCR C-tails, for which we had
previously shown a strong interaction with full-length GASP-2 (see
Figure 2). As shown in Figure 6A, mutant 377–838, resulting from
deletion of the N-terminal part of GASP-2 (upstream from the first
repeated motif), displayed interaction with all three receptor C-
tails ranging from 30% to 60% compared to the full-length GASP-
2. Conversely, mutant 470–838, corresponding to the C-terminal
domain of GASP-2, displayed almost no interaction with the three
GPCR C-tails tested (Figure 6A). As it was observed for GASP-1,
these results suggested that the central portion and the two GASP
motifs of GASP-2 are important for its interaction with GPCRs.
In a second step, we focused on the two GASP motifs of GASP-
2. As shown in Figure 6B, we replaced the four most conserved
residues from these motifs (SWFW) by alanines, either individually
(GASP2-m1 and GASP2-m2) or in combination (GASP2-dm).
The resulting mutants were probed for their interaction with
ADRB1, M1, and CALCR C-tails: compared to wild-type GASP-
2, both GASP2-m1 and -m2 displayed a strong decrease in their
interaction with ADRB1 and M1 C-tails, but they retained around
70% interaction with CALCR. For the double mutant, GASP2-
dm, almost no interaction was detected with the ADRB1 and M1
C-tails and a weak interaction was measured with the CALCR C-
tail. Altogether, these results indicated that the GASP motif plays a
crucial role in the interaction between GASP-2 and GPCRs.
Interestingly, site directed mutagenesis experiments pointed to the
highly conserved SWFW sequence within the GASP motif as a key
element for interaction with GPCR C-tails.
A Small Synthetic Peptide Derived from the GASP Motif is
Capable of Disrupting Interactions between GASPs and
GPCRs
We further investigated whether small synthetic peptides
containing the GASP motif could compete with GASPs for
interaction with GPCRs. In a first step, we performed competition
experiments with a synthetic peptide of 24 amino acids containing
the first GASP motif of GASP-2 (GASP peptide). Peptide
concentrations ranging from 1 to 250 mM were tested for their
capacity to disrupt the interaction between ADRB1 C-tail and
GASP-2. As shown in Figure 7A, increasing amounts of peptide
led to a decrease in the amount of GASP-2 that was retained by
the ADRB1 C-tail, while addition of the highest dose of a
scrambled peptide did not affect this interaction. Inhibitions of
6566% and 7666% were obtained with 100 mM and 250 mM
GASP peptide, respectively.
In a second step, we used a single peptide concentration
(150 mM) in competition experiments with four different receptor
C-tails, ADRB1, M1, CALCR, and TXA2, and three different
GASPs, GASP-1 and -2 that contain GASP motifs and GASP-7
that does not. Figure 7B displays a representative experiment for
ADRB1 C-tail and the three GASPs. Addition of 150 mM GASP
peptide almost completely prevented the interaction between
GASP-1, -2, -7 and the ADRB1 C-tail, while scrambled peptide
did not. Quantifications revealed that in the presence of 150 mM
of GASP peptide, the four receptor C-tails retained between 6%
and 35% of GASP-1, -2 and -7 compared to control values
(Figure 7C). Altogether, these results confirmed that the GASP
motif is mandatory for the interaction of GASPs with GPCRs.
Moreover, the interaction between GASP-7, which does not
exhibit the GASP motif, and GPCRs was also inhibited by the
GASP peptide suggesting that the two GASP subfamilies (with or
without GASP motif) most likely interact with the same region of
the GPCR carboxyl-terminal domain but with a distinct mode of
binding.
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Using SPR, we have shown that the central part of GASP-1 can
efficiently interact with full-length ADRB2 and CNR2. In a
second series of experiments, we examined whether the GASP
peptide could also compete with binding of full-length receptors to
the central domain of GASP-1. A single concentration of purified
ADRB2 or CNR2 were preincubated with different concentra-
tions of peptide before injecting the mixture to a surface with
central domain of GASP-1 prepared the same way as for the dose-
response experiments (Figure 4). Signals from free GST and from
buffer injections were subtracted from the curves. As expected
from GST-pull down competition experiments (Figure 7), prein-
cubation with 250 mM GASP peptide strongly decreased the
binding of both receptors to the central domain of GASP-1
(Figure 8A–B). This competition was dose-dependent with an IC50
estimated to be around 100 mM (Figure 8C). In contrast, a control
peptide where the conserved SWFW motif was changed to AAAA
only had a minor effect on the interaction (Figure 8). Overall, these
results indicate that the interaction between GPCRs and the
central part of GASP-1 is specific and that the GASP motifs in the
central domain are critical for the interaction with GPCRs.
Conclusions
In our previous study we have identified a novel family of
proteins from which the two first members, GASP-1 and GASP-2,
interact with GPCRs [6]. We provide here the first evidence that
other members of the GASP family can also interact with the C-
tail of GPCRs. Although some members, including GASP-6 and
GASP-9, displayed very weak level of interaction (about 1% to 2%
of the GASPs input), it was significantly higher than non-specific
interaction that was observed with GST alone or some receptor C-
tails fused to GST, such as MOR or TGFb. As GASP-1 has been
shown to modulate the postendocytic sorting of some GPCRs, our
results raise the possibility that other GASPs could be implicated in
similar functions, thus adding another level of complexity in
agonist-induced intracellular trafficking of GPCRs. A key issue will
then be to define how the selectivity of interaction between GASPs
and GPCRs is achieved in a cellular context.
Among the receptor C-tails that we have tested, ADRB1 is the
one that displays the highest level of interaction in vitro with GASP-
1 and GASP-2. This result is in contrast with previous results
showing a low interaction of GASP-1 with ADRB1 C-tail [10].
This discrepancy is most likely due to the fact that we used full-
length GASPs to perform our experiments, while Heydorn and
collaborators used a truncated form of GASP-1, corresponding to
amino-acids 898 to 1395. When we performed GST-pull down
experiments with a similar fragment of GASP-1 (corresponding to
amino acids 924 to 1395), only 5% of the input was retained by the
ADRB1 C-tail (data not shown), which is in agreement with the
results of Heydorn et al. [10]. Therefore, our results suggest that
the repertoire of GPCRs that interacts with GASP-1 could prove
to be even larger than previously anticipated [10].
While numerous GPCRs have been shown to interact with
GASP-1 [6,7,10], little is known about the molecular mechanisms
underlying the GASP-GPCR interaction. In the present study, we
show that a small repeated motif of 15 AA present 22 times in
GASP-1 and twice in GASP-2 to -5, is critical for the interaction of
GASPs with GPCR. Previous studies have only focused on the
conserved carboxyl-terminal region of the GASP family in the
interaction with GPCRs [6,7,10]. Although our results do not
exclude a role of this region (see Figure 3B), they clearly show that
this motif, that we named ‘‘GASP motif’’, is mandatory for the
interaction of GASPs from subfamily one with GPCRs and
Figure 5. The central domain of GASP-1 co-immunoprecipitates with GPCRs in cells. The central domain of GASP-1 (amino-acids 380 to
1073 of GASP-1 in pcDNA3.1) was transiently transfected in HEK293 cells stably expressing GFP-tagged ADRB1, ADRB2, CALCR or M1 receptor. HEK293
cells stably expressing MyrPalm-mYFP and transiently transfected with the central domain of GASP-1 were used as a negative control. The central
domain of GASP-1 co-immunoprecipitated with the four different GPCRs while no co-immunoprecipation was observed in cells expressing the central
domain of GASP-1 alone or co-expressing this domain with myristoylated-palmitoylated mYFP (MyrPalm-mYFP).
doi:10.1371/journal.pone.0056336.g005
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represents a new protein-protein interaction motif. These results,
together with the fact that GASP-1 contains 22 GASP motifs,
suggest that one GASP-1 molecule could interact with several
receptors. Moreover, beside their interaction with GPCRs, recent
studies have shown that different members of the GASP family can
interact with several non-GPCR proteins, including growth factor
receptors and ubiquitin ligases [13]. It is therefore tempting to
speculate that, like arrestins or multi-PDZ proteins, GASP-1 could
function as an adaptor protein assembling GPCRs and other
proteins in order to promote receptor function, signaling or
trafficking. Further studies are required to evaluate the functional
relevance of these interactions. Concerning GASPs from subfamily
two that do not contain GASP motifs, although weaker, we also
observed interactions in vitro with different GPCRs (Figures 2 and
7). Moreover, the interaction of GASP-7 with these different
GPCRs was also blocked by a synthetic peptide containing a
GASP motif (Figure 7). These data suggest that the two GASP
subfamilies (with or without GASP motif) most likely interact with
the same region within carboxyl-terminal domain of GPCRs but
with a distinct mode of binding. Although the region within
GASPs from subfamily 2 that promote the interaction with
GPCRs remains to identify, we propose that the conserved
carboxyl-terminal domain of the GASP family is involve in this
interaction as it is in GASP-1 and DOR interaction (Figures 3A
and 3B).
Figure 6. The GASP motif is critical for the interaction of GASP-
2 with GPCRs. A, GST-pull down experiments with two truncated
mutants of GASP-2 and ADRB1, M1 and CALCR C-tails. Grey boxes
represent the 15 AA GASP motifs. Deletion analysis revealed that the
central domain of GASP-2, which contains the two GASP motifs, is
critical for the interaction between GASP-2 and ADRB1, M1 and CALCR
C-tails. B, GST-pull down experiments with full-length GASP-2 where
one (GASP2-m1 and GASP2-m2) or both GASP motifs (GASP2-dm) were
mutated. Grey boxes represent the wild-type motifs and X represent the
mutant motifs. Consensus sequences are given for wild-type and
mutant motifs. Mutated amino acids are underlined. Site directed
mutagenesis analysis of these two repeated motifs showed that they
played a crucial role in the interaction of GASP-2 with the three receptor
C-tails tested here. Results are shown as percent of the wild-type GASP-
2 interaction and correspond to the mean 6 S.E.M of three
independent experiments.
doi:10.1371/journal.pone.0056336.g006
Figure 7. A small synthetic peptide derived from the GASP
motif of GASP-2 blocks the interaction between GASPs and
GPCR C-tails in GST-pull down experiments. A, GASP peptide
competes for the interaction between GASP-2 and GST-fused ADRB1 C-
tail. The scrambled peptide displayed no significant effect on the
interaction between GASP-2 and ADRB1. B, A fixed concentration of
GASP peptide (150 mM) inhibits the interaction between GASP-1, -2 or -
7 with ADRB1 C-tail, but not the scrambled peptide. C, Phosphor-
imaging quantification of the competition experiments for the
interaction between GASP-1, -2 and -7 and four different receptor C-
tails with GASP peptide. A fixed concentration of GASP peptide
(150 mM) strongly inhibited interactions of GASPs with ADRB1, M1,
CALCR and TXA2 C-tails. Results are represented as percent of the
interaction between the corresponding GASPs and GPCRs in absence of
peptide (mean 6 S.E.M of three independent experiments).
doi:10.1371/journal.pone.0056336.g007
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In this study we have set up an assay to examine the interaction
between immobilized GASP protein and detergent solubilized full-
length GPCRs using SPR. This approach is well-suited for a
quantitative study of the interactions between the GASP family of
proteins and any GPCR, because (i) most soluble proteins can be
expressed as GST fusion proteins and captured by anti-GST
antibodies without disturbing their function, (ii) immobilization of
GPCRs, which can easily impair their function [20], is avoided
and (iii) a minimum of GPCR handling is required. Optical
biosensors have previously been used to study the interaction
between recombinant GPCRs and G proteins [21–24], but this is
one of the first times that interactions between full-length GPCRs
and another GPCR interacting protein are studied with such
techniques. We have determined the dissociation rate constant for
the interaction of the central domain of GASP-1 with full-length
ADRB2 and CNR2 and estimated the affinity within an order or
magnitude. The dissociation rate constants and the affinities of the
two receptors are very close, indicating that the mode of
interaction with the central domain of GASP-1 is similar. The
slow dissociation constants (kd ,10
23 s21) suggest a high stability
of the GASP–GPCR complex. The relatively slow association rate
constant found in both cases does however not necessarily mean
that the association rate is slow under native conditions (i.e. in
cells), since the association rate–in contrast to the dissociation
rate–depends on the local concentration of the interacting
proteins. In agreement with GST-pull down experiments, SPR
competition experiments revealed that the GASP motif and the
amino-acids SWFW within this motif are strongly involved in
formation of GASP-GPCRs complexes. As GASP-1, arrestins can
form stable complexes with GPCRs [25,26], and have been
suggested to play a role in the postendocytic sorting of receptors
[7,27]. Interestingly, cell studies have indicated that arrestins can
also form transient complexes with GPCRs and that these
receptors are rapidly recycled instead of being degraded or slowly
recycled [26]. Whether GASPs can form transient complexes with
some GPCRs remains to be shown.
In summary, we have shown here that the GASP family is
divided into two sub-families based on their interaction with C-tail
of GPCRs: subfamily 1 comprises GASP-1 to -5 that strongly
interact with receptor C-tails and contain a small repeated motif,
the GASP motif, while sub-family 2 includes GASP-6 to -10 that
weakly interact with the receptor C-tails and does not contain the
GASP motif. We also report here the first molecular character-
ization of the interaction between GASPs and GPCRs. Our data
cleary demonstrate that the GASP motif mediates the interaction
of GASPs with G protein-coupled receptors and that a small
peptide containing this motif is capable of preventing the
interaction of GASPs with receptor C-tails and also full-length
GPCRs. This study clearly highlight that we have identified a
novel protein-protein interacting motif that is implicated in GPCR
interactions and might be a new target for investigation of the role
played by GASP in the modulation of the activity of GPCRs
in vivo.
Supporting Information
Figure S1 Crosswise comparison of the conserved
carboxyl-terminal domain of GASPs. Red color corresponds
to sequence identity between 90% and 100%, orange dark
between 75% and 90%, orange light between 45% and 75%, blue
dark between 25% and 44% and blue light less than 25%. In
addition to figure 1, this table shows that all GASPs display
sequence similarities in their carboxyl-terminal tail and reveals
very high sequence similarities between GASP-1 and GASP-2 as
well as high similarities between GASP-6, -7, -8 and -9.
(DOC)
Figure S2 GST-fusions of GPCR C-tails used in GST-
Pull down experiments. Purified proteins were separated by
SDS-PAGE and stained with coomassie blue.
(DOC)
Figure S3 Purification of the central domain of GASP-1,
ADRB2 and CNR2. Purified proteins were separated by SDS-
PAGE and stained with coomassie blue. A. line 1: crude extract,
line 2: cleared lysate, line 3: purified central domain of GASP-1. B.
Figure 8. GASP peptide prevents receptor binding to the
central domain of GASP-1 in SPR experiments. A, Binding of
1.1 mM ADRB2 alone or preincubated with either 250 mM GASP peptide
or 250 mM control peptide to captured central domain of GASP-1. B,
Binding of 0.30 mM CNR2 alone or preincubated with either 250 mM
GASP peptide or 250 mM control peptide to captured central domain of
GASP-1. All curves are double referenced and corrected for changes in
captured GASP density. C, Endpoint responses from competition
binding curves for 1.1 mM ADRB2 preincubated with a range of
concentrations of either GASP peptide (&) or control peptide (N) and
0.30 mM CNR2 preincubated with either GASP peptide (%) or control
peptide (#). The responses are normalized to the endpoint response
from an injection with receptor only (0 mM peptide).
doi:10.1371/journal.pone.0056336.g008
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line 4: membrane proteins of P. pastoris expressing ADRB2, line 5:
solubilized membrane proteins, line 6: purified ADRB2. C. line 7:
membrane proteins of P. pastoris expressing CNR2, line 8:
solubilized membrane proteins, line 9: purified CNR2. Arrow-
heads indicated purified proteins.
(DOC)
Figure S4 Overlay of GASP–GPCR saturation binding
curves with fit curves. Binding of the central domain of GASP-
1 to ADRB2 and CNR2 monitored with SPR. A, C. Overlay of the
dissociation phase of the central domain of GASP-1 binding to
ADRB2 (A) and CNR2 (C) with fit curves. B, D. Overlay of the full
binding curves for the central domain of GASP-1 binding to
ADRB2 (B) and CNR2 (D) with fit curves. In addition to the dose-
dependant binding of ADRB2 and CNR2 to the central domain of
GASP-1, the dissociation phase revealed a stable interaction
between the central domain of GASP-1 and the GPCRs.
(DOC)
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